AlexanderL. (1993). Age-related macular degeneration: The current understanding of the status of clinicopathology, diagnosis and management. Optometry, 64, 822–837.
2.
AmbrechtA., FindlayC., KaushalS., AspinallP., HillA., & DhillonB. (2000). Is cataract surgery justified in patients with age-related macular degeneration? A visual function and quality of life assessment. British Journal of Ophthalmology, 84, 1343–1438.
3.
BackmanH. A. (1996). L'Association D'Entraide en Basse Vision. L'Optometriste, 18, 23–27.
4.
HammondB. R., FuldK., & SnodderlyD. M. (1996). Iris color and macular pigment optical density. Experimental Eye Research, 62, 293–297.
5.
MangioneC. M., LeeP., GutierrezP., SpritzerK., BerryS., & HayR. (2001). Development of the 25-item National Eye Institute Visual Function Questionnaire. Archives of Ophthalmology, 119, 1050–1058.
6.
SmithW., AssinkJ., KleinR., MitchellP., KlaverC., KleinB., HofmanA., JensenS., WangJ., & deJongP. (2001). Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology, 108, 697–704.
7.
SmithW., MitchellP., & LeederS. R. (1996). Smoking and age-related maculopathy. The Blue Mountains eye study. Archives of Ophthalmology, 114, 1518–1523.
8.
SnodderlyD. M. (1995). Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. American Journal of Clinical Nutrition, 62, 1448S–1461S.
9.
ValbuenaM., Bandeen-RocheK., RubinG. S., MunozB., WestS. K., and the SEE Project Team. (1999). Self-reported assessment of visual function in a population-based study: The SEE Project. Investigative Ophthalmology and Vision Science, 40, 280–288.
10.
WilliamsR. A., BrodyB. L., ThomasR. G., KaplanR. M., & BrownS. I. (1998). The psychosocial impact of macular degeneration. Archives of Ophthalmology, 116, 514–520.